GO:0014047 glutamate secretion: Neurotransmitter Release Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014047 (glutamate secretion) describes the controlled release of glutamate, the most abundant excitatory neurotransmitter in the nervous system, by a cell.
• Glutamate secretion is not limited to neurons; it also occurs in pancreatic beta-cells, where glutamate pathways contribute to the control of insulin secretion.
• Glutamate is a central metabolite as well as a signaling molecule, linking secretion to broader metabolic roles in diverse organisms.
• Carrier-mediated glutamate export has been characterized in bacteria such as Corynebacterium glutamicum, showing that secretion mechanisms are evolutionarily widespread.
• Dysregulated glutamate release and metabolism are relevant to cancer biology, including rewired glutamate metabolism that diminishes the cytostatic action of L-asparaginase.
• Dietary and systemic glutamate can influence secretory processes in peripheral organs, such as gastric secretion in dogs.
Description
Glutamate secretion (GO:0014047) is the controlled release of glutamate by a cell, where glutamate acts as the most abundant excitatory neurotransmitter in the nervous system. This process is fundamental to intercellular communication, allowing a cell to export glutamate in a regulated manner rather than through passive leakage. Because glutamate is both a metabolite and a signaling molecule, its secretion sits at the intersection of metabolism and neurotransmission. Researchers study glutamate secretion to understand synaptic signaling, metabolic coupling, and how secretory pathways are co-opted in non-neuronal tissues. The process is not restricted to the nervous system. In pancreatic beta-cells, glutamate pathways participate in the control of insulin secretion, illustrating how the same molecule can serve endocrine as well as neural signaling roles. In microorganisms, carrier-mediated glutamate secretion has been documented in Corynebacterium glutamicum under biotin limitation, demonstrating that regulated glutamate export is an evolutionarily conserved strategy. These examples show that GO:0014047 is a broadly relevant biological process with implications for neuroscience, endocrinology, and industrial microbiology.
glutamate secretion At A Glance
| GO ID | GO:0014047 |
|---|---|
| GO term | glutamate secretion |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Definition | The controlled release of glutamate by a cell; glutamate is the most abundant excitatory neurotransmitter in the nervous system |
| Major function | Regulated export of glutamate for intercellular signaling and metabolic coordination |
| Representative cell types | Neurons and pancreatic beta-cells |
| Non-mammalian example | Carrier-mediated glutamate secretion in Corynebacterium glutamicum |
| Related metabolic theme | Glutamate participates in central metabolism as well as signaling |
What Is GO:0014047?
In simple terms, glutamate secretion is the process by which a cell deliberately releases glutamate to the outside. According to the QuickGO definition, GO:0014047 is the controlled release of glutamate by a cell, and glutamate is the most abundant excitatory neurotransmitter in the nervous system. The term is a biological process, meaning it describes a series of molecular events rather than a single component or activity. The word controlled distinguishes this regulated export from nonspecific leakage, and the definition emphasizes the signaling role of glutamate in the nervous system. At the same time, glutamate secretion can occur in non-neuronal contexts, such as pancreatic beta-cells, where glutamate pathways influence insulin secretion. Thus, GO:0014047 captures a regulated cellular export event whose physiological meaning depends on the cell type and organism.
Why Is glutamate secretion Important in Cell Biology?
Glutamate secretion is important because it is a core mechanism of excitatory signaling in the nervous system, where glutamate is the most abundant excitatory neurotransmitter. Beyond the brain, the same process contributes to endocrine regulation, as glutamate pathways in pancreatic beta-cells are involved in the control of insulin secretion. Because glutamate is also a central metabolite, its secretion connects signaling with metabolic flux, a theme highlighted by the many roles of glutamate in metabolism. Understanding GO:0014047 therefore helps researchers interpret normal physiology and disease states in which glutamate release or glutamate metabolism is altered, including cancer and peripheral secretory disorders. The process is also relevant to biotechnology, since carrier-mediated glutamate secretion has been studied in industrial microorganisms.
• Glutamate is the most abundant excitatory neurotransmitter in the nervous system, making its secretion central to excitatory signaling.
• Glutamate pathways in pancreatic beta-cells contribute to the control of insulin secretion, linking GO:0014047 to endocrine function.
• Glutamate serves broad metabolic roles, so its secretion intersects with cellular metabolism beyond neurotransmission.
• Carrier-mediated glutamate secretion occurs in bacteria such as Corynebacterium glutamicum, showing relevance to microbiology and biotechnology.
• Rewired glutamate metabolism can diminish the cytostatic action of L-asparaginase, connecting glutamate handling to cancer treatment responses.
• Dietary free glutamate can affect gastric secretion, indicating that glutamate-responsive secretory processes exist in peripheral organs.
• Glutamate receptor pharmacology depends on understanding glutamate availability, which is influenced by secretion and transport.
• Brain glutamate uptake and availability are critical topics in nutrition and neuroscience research.
• Studying glutamate secretion helps distinguish regulated release from metabolic leakage in diverse cell types.
• GO:0014047 provides a standardized annotation target for comparing glutamate release across species and tissues.
What Happens During glutamate secretion?
Glutamate availability and cellular context
In simple terms: Before a cell can release glutamate, glutamate must be present and available inside the cell.
Glutamate secretion depends on the cellular pool of glutamate, which is tied to broader glutamate metabolism. Glutamate has many roles in metabolism, so its availability reflects both synthetic and catabolic pathways. In pancreatic beta-cells, glutamate pathways are linked to the control of insulin secretion, indicating that the metabolic context shapes how glutamate is used and released. In bacteria, carrier-mediated glutamate secretion by Corynebacterium glutamicum under biotin limitation shows that secretion can be triggered by specific physiological conditions. These examples indicate that the first requirement for glutamate secretion is a regulated cellular glutamate pool whose size and fate depend on the cell type and its metabolic state.
Controlled release across the cell boundary
In simple terms: The cell then moves glutamate to the outside in a controlled way, not by simple leakage.
The defining event of GO:0014047 is the controlled release of glutamate by a cell. The QuickGO definition emphasizes that this release is controlled, distinguishing it from nonspecific loss of metabolites. In Corynebacterium glutamicum, glutamate secretion is carrier-mediated, providing a concrete example of a protein-dependent export mechanism. In mammalian systems, the concept of controlled glutamate release is central to excitatory neurotransmission, because glutamate is the most abundant excitatory neurotransmitter. Thus, the core step of glutamate secretion is a regulated export process that delivers glutamate to the extracellular space where it can act on target cells or participate in other extracellular roles.
Signaling and metabolic consequences
In simple terms: Once outside, glutamate can send signals or affect metabolism in nearby cells and tissues.
After release, glutamate can act as a signaling molecule. In the nervous system, this signaling role is fundamental because glutamate is the most abundant excitatory neurotransmitter. In pancreatic beta-cells, glutamate pathways participate in the control of insulin secretion, showing that released or intracellular glutamate can influence endocrine output. Glutamate receptor agonists and their stereochemical aspects are studied precisely because receptor activation depends on glutamate availability and recognition. In peripheral settings, free dietary glutamate can affect gastric secretion in dogs, illustrating that extracellular glutamate can modulate secretory functions outside the central nervous system. Together, these findings show that the consequences of glutamate secretion extend beyond a single signaling event and can influence multiple physiological processes.
Glutamate secretion in disease and metabolic rewiring
In simple terms: When glutamate release or metabolism goes wrong, it can contribute to disease or change how cells respond to treatment.
Altered glutamate handling is relevant to disease. Rewired glutamate metabolism diminishes the cytostatic action of L-asparaginase, linking glutamate pathways to cancer cell responses to therapy. Because glutamate is a central metabolite with many roles, changes in its secretion or metabolism can have broad consequences for cell physiology. In the brain, glutamate uptake and availability are important research topics, as reflected in discussions of brain uptake of glutamate. These observations support the idea that glutamate secretion and related metabolic pathways are not only physiological processes but also potential contributors to pathological states and treatment outcomes.
Key Genes Involved in GO:0014047 glutamate secretion
The following genes and proteins are representative of the cellular machinery, metabolism, and signaling context associated with glutamate secretion (GO:0014047), based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC1A1 (EAAT3) | Glutamate transporter family member involved in glutamate handling | Studying glutamate uptake and availability relevant to secretion |
| SLC1A2 (EAAT2) | Glutamate transporter family member in the nervous system | Context for extracellular glutamate regulation |
| SLC1A3 (EAAT1) | Glutamate transporter family member in the nervous system | Context for extracellular glutamate regulation |
| GRIN1 (NMDA receptor subunit) | Glutamate receptor subunit mediating excitatory signaling | Understanding postsynaptic responses to released glutamate |
| GRIA1 (AMPA receptor subunit) | Glutamate receptor subunit mediating fast excitatory signaling | Understanding receptor activation by secreted glutamate |
| GRIK1 (kainate receptor subunit) | Glutamate receptor subunit | Studying glutamate receptor pharmacology |
| GRM1 (mGluR1) | Metabotropic glutamate receptor | Investigating neuromodulatory roles of glutamate |
| GLS (glutaminase) | Enzyme contributing to glutamate production | Linking glutamate metabolism to secretion potential |
| GLUD1 (GDH) | Enzyme involved in glutamate metabolism | Studying metabolic control of glutamate pools |
| GOT1 (AST) | Enzyme in glutamate-related amino acid metabolism | Investigating metabolic rewiring in cancer |
| GOT2 (mAST) | Enzyme in glutamate-related amino acid metabolism | Investigating metabolic rewiring in cancer |
| ASNS (asparagine synthetase) | Enzyme linked to amino acid metabolism and L-asparaginase response | Studying glutamate metabolism and drug response |
| INS (insulin) | Hormone whose secretion is influenced by beta-cell glutamate pathways | Studying endocrine roles of glutamate |
| GCG (glucagon) | Pancreatic hormone related to islet function | Context for beta-cell secretory studies |
| SLC17A7 (VGLUT1) | Vesicular glutamate transporter family member | Studying vesicular glutamate release |
| SLC17A6 (VGLUT2) | Vesicular glutamate transporter family member | Studying vesicular glutamate release |
| SLC17A8 (VGLUT3) | Vesicular glutamate transporter family member | Studying vesicular glutamate release |
| Corynebacterium glutamicum carrier genes | Carrier-mediated glutamate secretion in bacteria | Modeling regulated glutamate export |
How Is glutamate secretion Regulated?
Glutamate secretion is regulated by the cellular metabolic state and by the availability of glutamate for release. In pancreatic beta-cells, glutamate pathways are integrated with the control of insulin secretion, indicating that nutrient and metabolic signals influence how glutamate is handled. In Corynebacterium glutamicum, biotin limitation triggers carrier-mediated glutamate secretion, showing that environmental or nutritional conditions can regulate export. Because glutamate participates in many metabolic reactions, its secretion is also influenced by the broader metabolic network that determines intracellular glutamate levels. In the nervous system, the extracellular fate of glutamate depends on uptake systems, which shape the signaling consequences of release. Together, these findings indicate that glutamate secretion is not a fixed process but is modulated by metabolic, nutritional, and cell-type-specific factors.
glutamate secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GOT1 | Cancer metabolic rewiring and L-asparaginase response | Knockout in cancer cell lines followed by drug treatment |
| GOT2 | Cancer metabolic rewiring and L-asparaginase response | Point-mutation models to test enzyme activity |
| ASNS | Amino acid metabolism and drug response | Overexpression and knockout in cancer cells |
| INS | Insulin secretion and beta-cell function | Knockout or knock-in in beta-cell models |
| SLC17A7 | Vesicular glutamate release | Tagged knock-in for localization studies |
Cancer and metabolic rewiring
Glutamate metabolism is rewired in some cancer contexts, and this rewiring diminishes the cytostatic action of L-asparaginase. Because glutamate secretion is tied to glutamate availability and metabolism, changes in these pathways could influence how tumor cells handle glutamate and respond to therapy. The many roles of glutamate in metabolism provide a framework for understanding why altering glutamate flux can have broad effects on cancer cell physiology.
Endocrine and metabolic disorders
Glutamate pathways in pancreatic beta-cells contribute to the control of insulin secretion, linking glutamate handling to endocrine function. Dysregulation of these pathways could therefore be relevant to conditions in which insulin secretion is altered, although the precise disease mechanisms require further study. The broader metabolic roles of glutamate also suggest that systemic glutamate balance may influence multiple organ systems.
Neurological and nutritional aspects
In the nervous system, glutamate is the most abundant excitatory neurotransmitter, and its release is central to excitatory signaling. Brain uptake of glutamate and its availability are important research topics, with implications for understanding how extracellular glutamate levels are maintained. Dietary free glutamate can affect gastric secretion in peripheral organs, indicating that nutritional glutamate can influence secretory physiology outside the brain. These observations connect glutamate secretion to both neurological and nutritional research.
From glutamate secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene control glutamate secretion? | Knockout cell model with glutamate release assays |
| Does a specific mutation alter glutamate handling? | Point-mutation knock-in cell model |
| Where is a glutamate-related protein localized? | Tagged knock-in with imaging |
| Does overexpression of a metabolic gene change glutamate secretion? | Overexpression cell model |
| Which pathways cooperate in glutamate secretion? | CRISPR library screening with functional readouts |
| How does glutamate secretion affect drug response? | Knockout or overexpression models combined with treatment |
How to Study the glutamate secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Extracellular glutamate assay | Glutamate released into the medium | Comparing control and knockout cells |
| Metabolic profiling | Levels of glutamate and related metabolites | Studying metabolic rewiring |
| Receptor activation assay | Functional glutamate availability | Testing receptor responses |
| Insulin secretion assay | Hormone release from beta-cells | Linking glutamate pathways to endocrine function |
| Gastric secretion measurement | Peripheral secretory response to glutamate | Nutritional and physiological studies |
| Imaging of tagged proteins | Localization of glutamate-related proteins | Tagged knock-in models |
| CRISPR library screening | Genes affecting glutamate secretion | Pathway discovery |
Measuring glutamate release
Glutamate secretion can be studied by measuring extracellular glutamate levels after controlled stimulation or under specific culture conditions. In bacteria, carrier-mediated glutamate secretion was characterized under biotin limitation, providing a model for how secretion can be triggered and measured. In mammalian systems, the concept of controlled glutamate release is central to neurotransmission research. These approaches help distinguish regulated secretion from baseline glutamate leakage.
Metabolic and flux analyses
Because glutamate is a central metabolite, metabolic analyses are important for understanding the pools that feed secretion. The many roles of glutamate in metabolism mean that secretion studies benefit from measuring related metabolites and pathway activities. In cancer research, rewired glutamate metabolism can be assessed in relation to drug responses such as L-asparaginase treatment. Such analyses connect secretion to broader metabolic states.
Receptor-based functional readouts
Glutamate receptor activation can be used as a functional readout of glutamate availability. Glutamate receptor agonists and their stereochemical aspects are studied to understand how receptors recognize glutamate. In the nervous system, glutamate is the most abundant excitatory neurotransmitter, so receptor-based assays are directly relevant to secretion studies. These readouts can complement direct measurements of glutamate release.
Endocrine and peripheral secretion assays
In pancreatic beta-cells, glutamate pathways are linked to insulin secretion, so assays of insulin release can be used alongside glutamate measurements. In peripheral organs, dietary free glutamate can affect gastric secretion, indicating that secretion assays in whole organisms or organ preparations can reveal glutamate-responsive processes. These models expand glutamate secretion research beyond the central nervous system.
How CRISPR Can Be Used to Study GO:0014047 glutamate secretion
Knockout
Knockout cell models can be used to test whether a candidate gene is required for glutamate secretion. For example, knocking out metabolic genes such as GOT1 or GOT2 can help determine their contribution to glutamate handling and drug response. In endocrine contexts, knocking out genes related to beta-cell glutamate pathways can reveal effects on insulin secretion. These models provide causal evidence linking specific genes to GO:0014047.
Point Mutation
Point-mutation models allow researchers to test the effect of specific amino acid changes on glutamate secretion-related proteins. This is valuable when a gene has enzymatic or transport functions, because a single mutation can alter activity without eliminating the protein. Such models can help distinguish loss-of-function from other mechanisms in glutamate metabolism and secretion.
Knock-in
Knock-in models, including tagged knock-ins, can be used to track the localization and dynamics of proteins involved in glutamate secretion. Tagged knock-in of vesicular glutamate transporter genes such as SLC17A7 can support imaging studies of glutamate release machinery. Knock-in approaches can also introduce disease-relevant variants to study their impact on secretion.
Overexpression
Overexpression models can test whether increasing the level of a glutamate-related gene is sufficient to alter secretion. For example, overexpressing metabolic enzymes or transporters can change intracellular glutamate pools and potentially affect release. In cancer research, overexpression of genes involved in glutamate metabolism can be combined with drug treatment to study L-asparaginase responses.
How EDITGENE Supports glutamate secretion Research
Researchers studying glutamate secretion-related genes often need to determine whether a candidate gene is causally involved in regulated glutamate release, how specific mutations affect protein function, and where the relevant proteins act within the cell. Addressing these questions requires reliable CRISPR models that can be tailored to the pathway of interest, from metabolic enzymes to transporters and receptors. EDITGENE provides a suite of services designed to support such studies with reproducible, publication-ready cell models.
Contact EDITGENE today to design your custom CRISPR model for glutamate secretion research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GRM2 Knockout HEK293 Cell Line | EDJ-KQ266 | Human | 2912 | Details Get a Quote |
| GIPC1 Knockout HEK293 Cell Line | EDJ-KQ2197 | Human | 10755 | Details Get a Quote |
| GJA1 Knockout HEK293 Cell Line | EDJ-KQ2803 | Human | 2697 | Details Get a Quote |
| KCNK2 Knockout HEK293 Cell Line | EDJ-KQ3681 | Human | 3776 | Details Get a Quote |
| KCNK1 Knockout HEK293 Cell Line | EDJ-KQ4262 | Human | 3775 | Details Get a Quote |
| BEST1 Knockout HEK293 Cell Line | EDJ-KQ6007 | Human | 7439 | Details Get a Quote |
| KCNK1 Knockout A-549 Cell Line | EDJ-KQ27956 | Human | 3775 | Details Get a Quote |
| KCNK1 Knockout HCT 116 Cell Line | EDJ-KQ27957 | Human | 3775 | Details Get a Quote |
| KCNK1 Knockout HeLa Cell Line | EDJ-KQ27958 | Human | 3775 | Details Get a Quote |
| GIPC1 Knockout A-549 Cell Line | EDJ-KQ22432 | Human | 10755 | Details Get a Quote |
| GIPC1 Knockout HCT 116 Cell Line | EDJ-KQ22433 | Human | 10755 | Details Get a Quote |
| GIPC1 Knockout HeLa Cell Line | EDJ-KQ22434 | Human | 10755 | Details Get a Quote |
| GJA1 Knockout A-549 Cell Line | EDJ-KQ23737 | Human | 2697 | Details Get a Quote |
| GJA1 Knockout HeLa Cell Line | EDJ-KQ23738 | Human | 2697 | Details Get a Quote |
| KCNK2 Knockout HeLa Cell Line | EDJ-KQ25670 | Human | 3776 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About glutamate secretion
What is glutamate secretion (GO:0014047)?
Glutamate secretion is the controlled release of glutamate by a cell, where glutamate is the most abundant excitatory neurotransmitter in the nervous system.
What genes are involved in glutamate secretion?
Genes involved in glutamate metabolism, transport, and receptor signaling are relevant, including metabolic enzymes and transporter families discussed in the literature.
Is glutamate secretion only found in neurons?
No. Glutamate pathways also operate in pancreatic beta-cells, where they contribute to the control of insulin secretion.
Can bacteria secrete glutamate?
Yes. Carrier-mediated glutamate secretion has been described in Corynebacterium glutamicum under biotin limitation.
How is glutamate secretion studied in the lab?
Researchers measure extracellular glutamate, analyze metabolic profiles, and use receptor-based functional readouts to assess glutamate availability.
Why is glutamate important in metabolism?
Glutamate has many roles in metabolism, connecting its secretion to broader cellular metabolic networks.
Does glutamate secretion matter in cancer?
Rewired glutamate metabolism can diminish the cytostatic action of L-asparaginase, linking glutamate pathways to cancer treatment responses.
Can diet affect glutamate-related secretion?
Free dietary glutamate can affect gastric secretion in dogs, indicating that nutritional glutamate can influence peripheral secretory processes.
What is the role of glutamate receptors in secretion research?
Glutamate receptor agonists and their stereochemical aspects are studied to understand how released glutamate is recognized by target cells.
How can CRISPR help study glutamate secretion?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes involved in glutamate secretion and metabolism.
Conclusion
Glutamate secretion (GO:0014047) is a regulated biological process in which cells release glutamate, the most abundant excitatory neurotransmitter in the nervous system. Its importance extends beyond neurotransmission to endocrine function, metabolism, and even microbial physiology. Understanding the genes and pathways that control glutamate secretion can illuminate normal physiology and disease states, including cancer and secretory disorders. CRISPR-based models provide a powerful way to test causal roles of candidate genes in this process, supporting both basic and translational research.
References
- 1. Maechler P. 2017. Glutamate pathways of the beta-cell and the control of insulin secretion.. Diabetes Res Clin Pract 131:149-153 PMID: 28743063
- 3. Gutmann M et al.. 1992. Carrier-mediated glutamate secretion by Corynebacterium glutamicum under biotin limitation.. Biochim Biophys Acta 1112(1):115-23 PMID: 1358200
- 4. Vogensen SB et al.. 2011. Glutamate receptor agonists: stereochemical aspects.. Curr Top Med Chem 11(7):887-906 PMID: 21291400
- 5. Walker MC et al.. 2016. The many roles of glutamate in metabolism.. J Ind Microbiol Biotechnol 43(2-3):419-30 PMID: 26323613
- 6. Hlozkova K et al.. 2024. Rewired glutamate metabolism diminishes cytostatic action of L-asparaginase.. Cancer Lett 605:217242 PMID: 39270769
- 7. Zolotarev V et al.. 2009. Effect of free dietary glutamate on gastric secretion in dogs.. Ann N Y Acad Sci 1170:87-90 PMID: 19686114
- 8. Attwell D. 2000. Brain uptake of glutamate: food for thought.. J Nutr 130(4S Suppl):1023S-5S PMID: 10736374
